CytRx Corp. buy melinda
Start price
19.05.17
/
50%
€2.73
Target price
25.05.17
€4.33
Performance (%)
23.59%
End price
25.05.17
€3.38
Summary
This prediction ended on 25.05.17 with a price of €3.38. The BUY prediction by melinda finished with a performance of 23.59%. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
CytRx Corp. | - | - | - | - |
iShares Core DAX® | -0.543% | 1.491% | 13.638% | 16.760% |
iShares Nasdaq 100 | -2.696% | -1.235% | 31.879% | 45.155% |
iShares Nikkei 225® | -2.863% | 2.491% | 12.078% | 7.840% |
iShares S&P 500 | -1.105% | 0.013% | 26.888% | 43.056% |
Comments by melinda for this prediction
In the thread CytRx Corp. diskutieren
Gesundheit | Biotechnologie | Vereinigte Staaten
Die Registrierung für Phase 2 abgeschlossen ist . Diskussion des Poster auf der ASCO am 3. Juni 2017. Phase - 3 - Test für das dritte Quartal 2017 geplant.
(Vom Mitglied beendet)